4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-071908
CIK 0001516479operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 6:36 PM ET
Size
7.5 KB
Accession
0001209191-15-071908
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-09-22−16,068→ 70,000 totalExercise: $1.62Exp: 2021-03-27→ Common Stock (16,068 underlying) - Exercise/Conversion
Common Stock
2015-09-22$1.62/sh+16,068$26,030→ 421,572 total
Footnotes (4)
- [F1]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 202,752 additional shares.
- [F2]The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- [F3]The option vested in 48 equal monthly installments and was fully vested and exercisable on March 28, 2015.
- [F4]On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 43,034 additional options.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 6:36 PM ET
- Size
- 7.5 KB